| 1 | Lipoprotein(a) immunoassays and their associations with coronary artery calcification and aortic valve calcification | 2.9 | 5 | Citations (PDF) |
| 2 | Characterisation of cotadutide's dual GLP‐1/glucagon receptor agonistic effects on glycaemic control using an in vivo human glucose regulation quantitative systems pharmacology model | 6.3 | 9 | Citations (PDF) |
| 3 | Apolipoprotein-CIII O-Glycosylation Is Associated with Micro- and Macrovascular Complications of Type 2 Diabetes | 4.4 | 12 | Citations (PDF) |
| 4 | Quantification of the effect of GLP‐1R agonists on body weight using in vitro efficacy information: An extension of the Hall body composition model | 2.7 | 2 | Citations (PDF) |
| 5 | The effects of
APOE4
and familial Alzheimer's disease mutations on free fatty acid profiles in mouse brain are age‐ and sex‐dependent | 3.8 | 2 | Citations (PDF) |
| 6 | Heart Rate Variability and Incident Type 2 Diabetes in General Population | 4.0 | 15 | Citations (PDF) |
| 7 | Associations of baseline glycemic status and its transitions with cognitive and physical functioning decline | 2.9 | 0 | Citations (PDF) |
| 8 | Four missense genetic variants in CUBN are associated with higher levels of eGFR in non-diabetes but not in diabetes mellitus or its subtypes: A genetic association study in Europeans | 3.8 | 5 | Citations (PDF) |
| 9 | Lipoprotein(a) is associated with a larger systemic burden of arterial calcification | 1.4 | 12 | Citations (PDF) |
| 10 | Cost-effectiveness and Return on Investment of a Nationwide Case-Finding Program for Familial Hypercholesterolemia in Children in the Netherlands | 8.5 | 39 | Citations (PDF) |
| 11 | Associations of blood pressure with all-cause and cause-specific mortality within different multimorbidity patterns among patients with type 2 diabetes | 2.0 | 0 | Citations (PDF) |
| 12 | IgG
N‐
glycans are associated with prevalent and incident complications of type 2 diabetes | 4.8 | 15 | Citations (PDF) |
| 13 | Subtyping Severe Hypercholesterolemia by Genetic Determinant to Stratify Risk of Coronary Artery Disease | 6.0 | 8 | Citations (PDF) |
| 14 | Spatial impact on life expectancy does not correct for familial hypercholesterolemia | 1.5 | 0 | Citations (PDF) |
| 15 | A novel integrated QSP model of in vivo human glucose regulation to support the development of a glucagon/GLP‐1 dual agonist | 2.7 | 11 | Citations (PDF) |
| 16 | Effect of FLAVAnols on bone turnover markers in type 2 diabetes mellitus–post hoc analysis from a 3-month randomized placebo-controlled trial | 0.6 | 0 | Citations (PDF) |
| 17 | Dutch Nationwide Implementation Program for familial hypercholesterolemia case finding in children: a cost-effectiveness and return on investment analysis | 2.2 | 0 | Citations (PDF) |
| 18 | Mortality in Pedigrees with Acute Intermittent Porphyria | 2.6 | 1 | Citations (PDF) |
| 19 | Sharing ICU Patient Data Responsibly Under the Society of Critical Care Medicine/European Society of Intensive Care Medicine Joint Data Science Collaboration: The Amsterdam University Medical Centers Database (AmsterdamUMCdb) Example* | 0.5 | 215 | Citations (PDF) |
| 20 | Lipoprotein(a) is robustly associated with aortic valve calciumHeart, 2021, 107, 1422-1428 | 3.9 | 57 | Citations (PDF) |
| 21 | Large-Scale Analysis of Apolipoprotein CIII Glycosylation by Ultrahigh Resolution Mass Spectrometry | 3.5 | 14 | Citations (PDF) |
| 22 | Genetic susceptibility, obesity and lifetime risk of type 2 diabetes: The ARIC study and Rotterdam Study | 2.9 | 13 | Citations (PDF) |
| 23 | Breakfast partly restores the anti-inflammatory function of high-density lipoproteins from patients with type 2 diabetes mellitus | 1.3 | 3 | Citations (PDF) |
| 24 | The effect of monomeric and oligomeric FLAVAnols in patients with type 2 diabetes and microalbuminuria (FLAVA-trial): A double-blind randomized controlled trial | 5.3 | 5 | Citations (PDF) |
| 25 | HDL associates with insulin resistance and beta-cell dysfunction in South Asian families at risk of type 2 diabetes | 2.4 | 11 | Citations (PDF) |
| 26 | Lipoprotein(a) is associated with incidence but not progression of aortic valve calcium | 2.2 | 1 | Citations (PDF) |
| 27 | Effects of Sex, Age, and Apolipoprotein E Genotype on Brain Ceramides and Sphingosine-1-Phosphate in Alzheimer’s Disease and Control Mice | 3.9 | 15 | Citations (PDF) |
| 28 | Cross-Laboratory Standardization of Preclinical Lipidomics Using Differential Mobility Spectrometry and Multiple Reaction Monitoring | 6.5 | 93 | Citations (PDF) |
| 29 | Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia | 11.1 | 236 | Citations (PDF) |
| 30 | Anxiety and depression in diabetes care: longitudinal associations with health-related quality of life | 3.4 | 66 | Citations (PDF) |
| 31 | Trajectories of BMI Before Diagnosis of Type 2 Diabetes: The Rotterdam Study | 4.0 | 24 | Citations (PDF) |
| 32 | Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment? | 1.5 | 54 | Citations (PDF) |
| 33 | Lipoprotein(a) plasma levels are not associated with incident microvascular complications in type 2 diabetes mellitus | 7.5 | 27 | Citations (PDF) |
| 34 | Letter by Weingärtner et al Regarding Article, “Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized, Controlled Trial” | 18.0 | 2 | Citations (PDF) |
| 35 | Sex difference in the incidence of microvascular complications in patients with type 2 diabetes mellitus: a prospective cohort study | 2.2 | 30 | Citations (PDF) |
| 36 | Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: many happy returns on investment? | 2.2 | 1 | Citations (PDF) |
| 37 | United Kingdom’s contribution to European research output in biomedical sciences: 2008–2017 | 0.4 | 0 | Citations (PDF) |
| 38 | Dietary antioxidant capacity and risk of type 2 diabetes mellitus, prediabetes and insulin resistance: the Rotterdam Study | 5.3 | 94 | Citations (PDF) |
| 39 | Statin treatment increases lipoprotein(a) levels in subjects with low molecular weight apolipoprotein(a) phenotype | 1.5 | 49 | Citations (PDF) |
| 40 | The effect of guideline revisions on vascular complications of type 2 diabetes | 3.5 | 4 | Citations (PDF) |
| 41 | Lp(A) Plasma Levels Are Not Associated With Microvascular Complications In T2d A Prospective Cohort Study | 1.5 | 0 | Citations (PDF) |
| 42 | Predictors and patterns of eating behaviors across childhood: Results from The Generation R study | 2.8 | 40 | Citations (PDF) |
| 43 | Novel metabolic indices and incident type 2 diabetes among women and men: the Rotterdam Study | 7.5 | 74 | Citations (PDF) |
| 44 | An integrative cross-omics analysis of DNA methylation sites of glucose and insulin homeostasis | 13.7 | 84 | Citations (PDF) |
| 45 | Mortality Risk Associated With Truncating Founder Mutations in Titin | 2.9 | 9 | Citations (PDF) |
| 46 | Dietary Sargassum fusiforme improves memory and reduces amyloid plaque load in an Alzheimer’s disease mouse model | 3.4 | 84 | Citations (PDF) |
| 47 | The emerging concept of “individualized cholesterol-lowering therapy”: A change in paradigm 2019, 199, 111-116 | | 39 | Citations (PDF) |
| 48 | Transcription factor 7-like 2 gene links increased in vivo insulin synthesis to type 2 diabetes | 9.7 | 16 | Citations (PDF) |
| 49 | Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapy | 3.1 | 39 | Citations (PDF) |
| 50 | Group cognitive behavioural therapy and weight regain after diet in type 2 diabetes: results from the randomised controlled POWER trial | 7.5 | 30 | Citations (PDF) |
| 51 | Eating behavior and body composition across childhood: a prospective cohort study | 4.3 | 70 | Citations (PDF) |
| 52 | ClinVar database of global familial hypercholesterolemia‐associated DNA variants | 4.5 | 106 | Citations (PDF) |
| 53 | Adaptation of ACMG/AMP guidelines for variant interpretation in familial hypercholesterolemia - A clingen fh expert panel pilot study | 1.5 | 1 | Citations (PDF) |
| 54 | High Diabetes Distress Among Ethnic Minorities Is Not Explained by Metabolic, Cardiovascular, or Lifestyle Factors: Findings From the Dutch Diabetes Pearl Cohort | 6.2 | 29 | Citations (PDF) |
| 55 | Clinical Genetic Testing for Familial Hypercholesterolemia | 2.3 | 569 | Citations (PDF) |
| 56 | Reversal of Aging‐Induced Increases in Aortic Stiffness by Targeting Cytoskeletal Protein‐Protein Interfaces | 4.0 | 25 | Citations (PDF) |
| 57 | Plasma protein N-glycan signatures of type 2 diabetes | 2.0 | 66 | Citations (PDF) |
| 58 | Pleiotropic Effect of Human ApoE4 on Cerebral Ceramide and Saturated Fatty Acid Levels | 2.6 | 8 | Citations (PDF) |
| 59 | Proprotein convertase subtilisin/kexin 9 inhibition in patients with familial hypercholesterolemia: Initial clinical experience | 3.1 | 34 | Citations (PDF) |
| 60 | Low-density lipoprotein receptor–negative compound heterozygous familial hypercholesterolemia: Two lifetime journeys of lipid-lowering therapy | 3.1 | 4 | Citations (PDF) |
| 61 | Novel protein biomarkers associated with coronary artery disease in statin-treated patients with familial hypercholesterolemia | 3.1 | 36 | Citations (PDF) |
| 62 | Effect of diet-induced weight loss on lipoprotein(a) levels in obese individuals with and without type 2 diabetes | 7.5 | 33 | Citations (PDF) |
| 63 | Low-density lipoprotein receptor mutational analysis in diagnosis of familial hypercholesterolemia | 4.0 | 42 | Citations (PDF) |
| 64 | Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia | 1.5 | 68 | Citations (PDF) |
| 65 | Age at natural menopause and life expectancy with and without type 2 diabetes | 2.9 | 0 | Citations (PDF) |
| 66 | An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans | 4.2 | 733 | Citations (PDF) |
| 67 | The anti-inflammatory function of high-density lipoprotein in type II diabetes: A systematic review | 3.1 | 29 | Citations (PDF) |
| 68 | Carotid artery plaques and intima medial thickness in familial hypercholesteraemic patients on long-term statin therapy: A case control study | 1.5 | 26 | Citations (PDF) |
| 69 | Serum Levels of Apolipoproteins and Incident Type 2 Diabetes: A Prospective Cohort Study | 6.2 | 45 | Citations (PDF) |
| 70 | A Mendelian Randomization Study of Metabolite Profiles, Fasting Glucose, and Type 2 Diabetes | 4.2 | 47 | Citations (PDF) |
| 71 | Individual and partner's level of occupation and the association with HbA1c levels in people with Type 2 diabetes mellitus: the Dutch Diabetes Pearl cohort | 2.9 | 4 | Citations (PDF) |
| 72 | Metabolomics based markers predict type 2 diabetes in a 14-year follow-up study | 2.8 | 90 | Citations (PDF) |
| 73 | Testing the direction of effects between child body composition and restrictive feeding practices: results from a population-based cohort | 4.7 | 90 | Citations (PDF) |
| 74 | Soluble LR11 associates with aortic root calcification in asymptomatic treated male patients with familial hypercholesterolemia | 1.5 | 7 | Citations (PDF) |
| 75 | IgG glycan patterns are associated with type 2 diabetes in independent European populations | 2.0 | 116 | Citations (PDF) |
| 76 | Introduction of the DiaGene study: clinical characteristics, pathophysiology and determinants of vascular complications of type 2 diabetes | 3.4 | 20 | Citations (PDF) |
| 77 | Predictors of Diet-Induced Weight Loss in Overweight Adults with Type 2 Diabetes | 2.3 | 8 | Citations (PDF) |
| 78 | Lomitapide affects HDL composition and function | 1.5 | 13 | Citations (PDF) |
| 79 | Levels of the soluble LDL receptor-relative LR11 decrease in overweight individuals with type 2 diabetes upon diet-induced weight loss | 1.5 | 11 | Citations (PDF) |
| 80 | Genomic prediction of coronary heart disease | 2.2 | 328 | Citations (PDF) |
| 81 | Familial hypercholesterolaemia: cholesterol efflux and coronary disease | 3.0 | 37 | Citations (PDF) |
| 82 | A stable isotope method for in vivo assessment of human insulin synthesis and secretion | 2.2 | 6 | Citations (PDF) |
| 83 | Diet-induced weight loss and markers of endothelial dysfunction and inflammation in treated patients with type 2 diabetes | 0.7 | 15 | Citations (PDF) |
| 84 | The clinical value of metabolic syndrome and risks of cardiometabolic events and mortality in the elderly: the Rotterdam study | 9.4 | 50 | Citations (PDF) |
| 85 | Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel | 21.7 | 396 | Citations (PDF) |
| 86 | Study on inflammation-related genes and microRNAs, with special emphasis on the vascular repair factor HGF and miR-574-3p, in monocytes and serum of patients with T2D | 3.4 | 26 | Citations (PDF) |
| 87 | Hyperoxia increases arterial oxygen pressure during exercise in type 2 diabetes patients: a feasibility study | 3.0 | 21 | Citations (PDF) |
| 88 | Discriminative Ability of Plasma Branched-Chain Amino Acid Levels for Glucose Intolerance in Families At Risk for Type 2 Diabetes | 1.9 | 7 | Citations (PDF) |
| 89 | Tobacco smoking is associated with DNA methylation of diabetes susceptibility genes | 7.5 | 47 | Citations (PDF) |
| 90 | Prognostic Value of Coronary Computed Tomography Imaging in Patients at High Risk Without Symptoms of Coronary Artery Disease | 1.8 | 24 | Citations (PDF) |
| 91 | Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study | 21.7 | 242 | Citations (PDF) |
| 92 | ADAMTS13 activity as a novel risk factor for incident type 2 diabetes mellitus: a population-based cohort study | 7.5 | 27 | Citations (PDF) |
| 93 | LR11/SorLA links triglyceride-rich lipoproteins to risk of developing cardiovascular disease in FH patients | 1.5 | 9 | Citations (PDF) |
| 94 | Fine mapping the CETP region reveals a common intronic insertion associated to HDL-C | 5.5 | 9 | Citations (PDF) |
| 95 | Cardiac computed tomography imaging in familial hypercholesterolaemia | 4.0 | 17 | Citations (PDF) |
| 96 | Type 2 Diabetes Monocyte MicroRNA and mRNA Expression: Dyslipidemia Associates with Increased Differentiation-Related Genes but Not Inflammatory Activation | 2.3 | 25 | Citations (PDF) |
| 97 | Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation | 2.0 | 70 | Citations (PDF) |
| 98 | Increased Aortic Valve Calcification in Familial Hypercholesterolemia | 2.3 | 64 | Citations (PDF) |
| 99 | Association of IL-6 and a Functional Polymorphism in the IL-6 Gene with Cardiovascular Events in Patients with CKD | 4.2 | 69 | Citations (PDF) |
| 100 | Lipid droplets hypertrophy: a crucial determining factor in insulin regulation by adipocytes | 3.4 | 30 | Citations (PDF) |
| 101 | Lipoprotein (a) levels are not associated with carotid plaques and carotid intima media thickness in statin-treated patients with familial hypercholesterolemia | 1.5 | 34 | Citations (PDF) |
| 102 | Lomitapide treatment highly affects lipoprotein profile and HDL functionality in patients with familial hypercholesterolemia | 1.5 | 0 | Citations (PDF) |
| 103 | Afamelanotide for Erythropoietic Protoporphyria | 34.5 | 269 | Citations (PDF) |
| 104 | Health Status and Psychological Distress in Patients with Non-compaction Cardiomyopathy: The Role of Burden Related to Symptoms and Genetic Vulnerability | 1.3 | 9 | Citations (PDF) |
| 105 | Expression and Gene Variation Studies Deny Association of Human HSD3B1 Gene With Aldosterone Production or Blood Pressure | 2.0 | 8 | Citations (PDF) |
| 106 | Quantitative Contrast-Enhanced Ultrasound of Intraplaque Neovascularization in Patients with Carotid Atherosclerosis | 0.7 | 29 | Citations (PDF) |
| 107 | Genome of the Netherlands population-specific imputations identify an ABCA6 variant associated with cholesterol levels | 13.7 | 51 | Citations (PDF) |
| 108 | Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemia | 1.5 | 30 | Citations (PDF) |
| 109 | Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci | 25.2 | 413 | Citations (PDF) |
| 110 | Lipoprotein(a) levels are associated with aortic valve calcification in asymptomatic patients with familial hypercholesterolaemia | 7.3 | 104 | Citations (PDF) |
| 111 | Refinement of Variant Selection for the LDL Cholesterol Genetic Risk Score in the Diagnosis of the Polygenic Form of Clinical Familial Hypercholesterolemia and Replication in Samples from 6 Countries | 1.1 | 199 | Citations (PDF) |
| 112 | Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcome | 2.2 | 407 | Citations (PDF) |
| 113 | Post-glucose-load urinary C-peptide and glucose concentration obtained during OGTT do not affect oral minimal model-based plasma indices | 2.5 | 3 | Citations (PDF) |
| 114 | Decreased Serum Level of miR-146a as Sign of Chronic Inflammation in Type 2 Diabetic Patients | 2.3 | 112 | Citations (PDF) |
| 115 | A genetic variant in <i><scp>SLC</scp>6A20</i> is associated with Type 2 diabetes in white‐European and Chinese populations | 2.9 | 8 | Citations (PDF) |
| 116 | Arterial stiffness and hypertension in a large population of untreated individuals | 2.1 | 29 | Citations (PDF) |
| 117 | Utility of contrast-enhanced ultrasound for the assessment of the carotid artery wall in patients with Takayasu or giant cell arteritis | 1.4 | 75 | Citations (PDF) |
| 118 | Impact of gender on the density of intraplaque neovascularization: A quantitative contrast-enhanced ultrasound study | 1.5 | 9 | Citations (PDF) |
| 119 | Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation | 3.1 | 104 | Citations (PDF) |
| 120 | Predicting non-adherence in patients with familial hypercholesterolemia | 2.0 | 28 | Citations (PDF) |
| 121 | Increased aortic stiffness and blood pressure in non‐classic Pompe disease | 3.2 | 12 | Citations (PDF) |
| 122 | Leveraging Cross-Species Transcription Factor Binding Site Patterns: From Diabetes Risk Loci to Disease Mechanisms | 33.6 | 124 | Citations (PDF) |
| 123 | Assessment of carotid atherosclerosis, intraplaque neovascularization, and plaque ulceration using quantitative contrast-enhanced ultrasound in asymptomatic patients with diabetes mellitus | 1.4 | 42 | Citations (PDF) |
| 124 | Gene-Age Interactions in Blood Pressure Regulation: A Large-Scale Investigation with the CHARGE, Global BPgen, and ICBP Consortia | 6.5 | 127 | Citations (PDF) |
| 125 | Effects of Long-Term Averaging of Quantitative Blood Pressure Traits on the Detection of Genetic Associations | 6.5 | 81 | Citations (PDF) |
| 126 | Cascade screening based on genetic testing is cost-effective: Evidence for the implementation of models of care for familial hypercholesterolemia | 3.1 | 166 | Citations (PDF) |
| 127 | Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility | 25.2 | 1,037 | Citations (PDF) |
| 128 | The aging kidney revisited: A systematic review | 11.6 | 236 | Citations (PDF) |
| 129 | Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation | 2.2 | 342 | Citations (PDF) |
| 130 | Excess mortality in mothers of patients with polycystic ovary syndrome | 1.0 | 7 | Citations (PDF) |
| 131 | Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity | 3.2 | 70 | Citations (PDF) |
| 132 | Treatment of a compound heterozygous familial hypercholesterolemia patient with lomitapide | 1.5 | 0 | Citations (PDF) |
| 133 | Common variants in PCSK1 influence blood pressure and body mass index | 2.5 | 11 | Citations (PDF) |
| 134 | Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach | 3.0 | 17 | Citations (PDF) |
| 135 | Failing beta-cell adaptation in South Asian families with a high risk of type 2 diabetes | 2.2 | 27 | Citations (PDF) |
| 136 | The effect of LDLR-negative genotype on CT coronary atherosclerosis in asymptomatic statin treated patients with heterozygous familial hypercholesterolemia | 1.5 | 32 | Citations (PDF) |
| 137 | Current status and future developments of contrast-enhanced ultrasound of carotid atherosclerosis | 1.8 | 84 | Citations (PDF) |
| 138 | Carotid intima-media thickness for cardiovascular risk assessment: Systematic review and meta-analysis | 1.5 | 279 | Citations (PDF) |
| 139 | Assessment of subclinical atherosclerosis and intraplaque neovascularization using quantitative contrast-enhanced ultrasound in patients with familial hypercholesterolemia | 1.5 | 33 | Citations (PDF) |
| 140 | Carotid Plaque Burden as a Measure of Subclinical Coronary Artery Disease in Patients With Heterozygous Familial Hypercholesterolemia | 1.8 | 31 | Citations (PDF) |
| 141 | Assessment of subclinical atherosclerosis using contrast-enhanced ultrasound | 1.4 | 22 | Citations (PDF) |
| 142 | Resistin and all-cause and cardiovascular mortality: effect modification by adiponectin in end-stage kidney disease patients | 0.8 | 31 | Citations (PDF) |
| 143 | The Role of Adiposity in Cardiometabolic Traits: A Mendelian Randomization Analysis | 8.0 | 196 | Citations (PDF) |
| 144 | The Impact of Partial and Complete Loss-of-Function Mutations in Endothelial Lipase on High-Density Lipoprotein Levels and Functionality in Humans | 3.8 | 59 | Citations (PDF) |
| 145 | The effect of LP(a) in patients with heterozygous familial hypercholesterolemia on coronary plaque burden and calcium score determined by CT | 2.2 | 0 | Citations (PDF) |
| 146 | The fat-mass and obesity-associated gene (FTO) predicts mortality in chronic kidney disease of various severity | 0.8 | 16 | Citations (PDF) |
| 147 | Dietary intake of plant sterols stably increases plant sterol levels in the murine brain | 3.6 | 116 | Citations (PDF) |
| 148 | Mortality of Inherited Arrhythmia Syndromes | 3.8 | 42 | Citations (PDF) |
| 149 | Meat Consumption and Its Association With C-Reactive Protein and Incident Type 2 Diabetes | 6.2 | 82 | Citations (PDF) |
| 150 | Common Genetic Variation in the 3′-
BCL11B
Gene Desert Is Associated With Carotid-Femoral Pulse Wave Velocity and Excess Cardiovascular Disease Risk | 3.8 | 97 | Citations (PDF) |
| 151 | Characterization of coagulation factor synthesis in nine human primary cell types | 3.4 | 36 | Citations (PDF) |
| 152 | Prediction of 9-year cardiovascular outcomes by myocardial perfusion imaging in patients with normal exercise electrocardiographic testing | 1.4 | 9 | Citations (PDF) |
| 153 | Patients with chronic gastrointestinal ischemia have a higher cardiovascular disease risk and mortality | 1.5 | 12 | Citations (PDF) |
| 154 | Far-Wall Pseudoenhancement During Contrast-Enhanced Ultrasound of the Carotid Arteries: Clinical Description and In Vitro Reproduction | 2.0 | 70 | Citations (PDF) |
| 155 | Red wine polyphenols do not lower peripheral or central blood pressure in high normal blood pressure and hypertension | 2.0 | 35 | Citations (PDF) |
| 156 | Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes | 25.2 | 1,878 | Citations (PDF) |
| 157 | Nitrite- and nitroxyl-induced relaxation in porcine coronary (micro-) arteries: Underlying mechanisms and role as endothelium-derived hyperpolarizing factor(s) | 9.1 | 8 | Citations (PDF) |
| 158 | Long-term prognostic value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography | 1.8 | 23 | Citations (PDF) |
| 159 | 15-Year outcome after normal exercise 99mTc-sestamibi myocardial perfusion imaging: What is the duration of low risk after a normal scan? | 1.8 | 22 | Citations (PDF) |
| 160 | A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance | 25.2 | 835 | Citations (PDF) |
| 161 | Red wine extract protects against oxidative-stress-induced endothelial senescence | 6.2 | 27 | Citations (PDF) |
| 162 | Outcome and Complications After Implantable Cardioverter Defibrillator Therapy in Hypertrophic Cardiomyopathy | 4.4 | 164 | Citations (PDF) |
| 163 | Low-density lipoprotein receptor mutations generate synthetic genome-wide associations | 3.0 | 8 | Citations (PDF) |
| 164 | Meta-Analysis of Genome-Wide Association Studies in >80 000 Subjects Identifies Multiple Loci for C-Reactive Protein Levels | 18.0 | 494 | Citations (PDF) |
| 165 | Mortality Risk of Untreated Myosin-Binding Protein C–Related Hypertrophic Cardiomyopathy | 2.3 | 30 | Citations (PDF) |
| 166 | Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk | 37.9 | 2,008 | Citations (PDF) |
| 167 | Apolipoprotein CI Knock-Out Mice Display Impaired Memory Functions | 2.6 | 23 | Citations (PDF) |
| 168 | Chronic Gastrointestinal Ischemia Due to Atherosclerotic Narrowing is Related to Classical Risk Factors for Cardiovascular Disease | 0.9 | 0 | Citations (PDF) |
| 169 | Liver X receptor activation restores memory in aged AD mice without reducing amyloid | 3.4 | 135 | Citations (PDF) |
| 170 | Maternal inheritance of familial hypercholesterolemia caused by the V408M low-density lipoprotein receptor mutation increases mortality | 1.5 | 38 | Citations (PDF) |
| 171 | Accelerated subclinical coronary atherosclerosis in patients with familial hypercholesterolemia | 1.5 | 89 | Citations (PDF) |
| 172 | More on advances in imaging angiogenesis and inflammation in atherosclerosis | 4.1 | 0 | Citations (PDF) |
| 173 | Aging and Left Ventricular Mass and Function in People with End‐Stage Renal Disease | 2.9 | 7 | Citations (PDF) |
| 174 | Cerebral Accumulation of Dietary Derivable Plant Sterols does not Interfere with Memory and Anxiety Related Behavior in Abcg5−/− Mice | 3.3 | 41 | Citations (PDF) |
| 175 | Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons | 7.5 | 22 | Citations (PDF) |
| 176 | A Methodological Perspective on Genetic Risk Prediction Studies in Type 2 Diabetes: Recommendations for Future Research | 5.1 | 30 | Citations (PDF) |
| 177 | Impact of an Alerting Clinical Decision Support System for Glucose Control on Protocol Compliance and Glycemic Control in the Intensive Cardiac Care Unit | 4.6 | 29 | Citations (PDF) |
| 178 | Inflammation and Asymmetric Dimethylarginine for Predicting Death and Cardiovascular Events in ESRD Patients | 4.2 | 101 | Citations (PDF) |
| 179 | CT coronary plaque burden in asymptomatic patients with familial hypercholesterolaemiaHeart, 2011, 97, 1151-1157 | 3.9 | 53 | Citations (PDF) |
| 180 | Apolipoprotein Isoform
E4
Does Not Increase Coronary Heart Disease Risk in Carriers of Low-Density Lipoprotein Receptor Mutations | 3.8 | 20 | Citations (PDF) |
| 181 | A frequent variant in the ABCA1 gene is associated with increased coronary heart disease risk and a better response to statin treatment in familial hypercholesterolemia patients | 2.2 | 13 | Citations (PDF) |
| 182 | Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure | 25.2 | 424 | Citations (PDF) |
| 183 | Total Zinc Intake May Modify the Glucose-Raising Effect of a Zinc Transporter (SLC30A8) Variant | 4.2 | 100 | Citations (PDF) |
| 184 | Daily Red Wine Consumption Improves Vascular Function by a Soluble Guanylyl Cyclase-Dependent Pathway | 2.0 | 29 | Citations (PDF) |
| 185 | Does aortic stiffness improve the prediction of coronary heart disease in elderly? The Rotterdam Study | 2.5 | 31 | Citations (PDF) |
| 186 | Validity of Type D personality in Iceland: association with disease severity and risk markers in cardiac patients | 2.3 | 31 | Citations (PDF) |
| 187 | Genetic risk profiling for prediction of type 2 diabetes | 1.6 | 35 | Citations (PDF) |
| 188 | Cascade Screening for Familial Hypercholesterolemia (FH) | 1.6 | 64 | Citations (PDF) |
| 189 | Genetic polymorphisms in the DRD2, DRD3, and SLC6A3 gene in elderly patients with delirium | 1.5 | 34 | Citations (PDF) |
| 190 | Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe | 4.0 | 99 | Citations (PDF) |
| 191 | Alterations in Brain Cholesterol Metabolism in the APPSLxPS1mut mouse, a Model for Alzheimer's Disease | 2.6 | 38 | Citations (PDF) |
| 192 | Molecular imaging of inflammation and intraplaque vasa vasorum: A step forward to identification of vulnerable plaques? | 1.8 | 57 | Citations (PDF) |
| 193 | Noninvasive Imaging of the Vulnerable Atherosclerotic Plaque | 3.0 | 72 | Citations (PDF) |
| 194 | The association of the dopamine transporter gene and the dopamine receptor 2 gene with delirium, a meta‐analysis | 1.5 | 54 | Citations (PDF) |
| 195 | Biological, clinical and population relevance of 95 loci for blood lipids | 37.9 | 3,470 | Citations (PDF) |
| 196 | Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge | 25.2 | 619 | Citations (PDF) |
| 197 | Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis | 25.2 | 1,714 | Citations (PDF) |
| 198 | Two Years after Molecular Diagnosis of Familial Hypercholesterolemia: Majority on Cholesterol-Lowering Treatment but a Minority Reaches Treatment Goal | 2.3 | 114 | Citations (PDF) |
| 199 | Improvement of Risk Prediction by Genomic Profiling: Reclassification Measures Versus the Area Under the Receiver Operating Characteristic Curve | 3.3 | 63 | Citations (PDF) |
| 200 | A Prospective Analysis of Elevated Fasting Glucose Levels and Cognitive Function in Older People | 4.2 | 83 | Citations (PDF) |
| 201 | Interactions of Dietary Whole-Grain Intake With Fasting Glucose– and Insulin-Related Genetic Loci in Individuals of European Descent | 6.2 | 136 | Citations (PDF) |
| 202 | Interactions between dietary vitamin E intake and SIRT1 genetic variation influence body mass index | 4.7 | 25 | Citations (PDF) |
| 203 | Carotid Atherosclerosis Progression in Familial Hypercholesterolemia Patients | 2.9 | 22 | Citations (PDF) |
| 204 | The risk of tendon xanthomas in familial hypercholesterolaemia is influenced by variation in genes of the reverse cholesterol transport pathway and the low-density lipoprotein oxidation pathway | 2.2 | 47 | Citations (PDF) |
| 205 | Clinical and genetic factors influencing cardiovascular risk in patients with familial hypercholesterolemia | 0.0 | 8 | Citations (PDF) |
| 206 | Efficacy and Safety of Mipomersen, an Antisense Inhibitor of Apolipoprotein B, in Hypercholesterolemic Subjects Receiving Stable Statin Therapy | 2.3 | 156 | Citations (PDF) |
| 207 | Contrast-Enhanced Ultrasound Imaging of the Vasa Vasorum | 6.1 | 171 | Citations (PDF) |
| 208 | Insulin metabolism and the risk of Alzheimer disease | 1.0 | 321 | Citations (PDF) |
| 209 | New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk | 25.2 | 2,115 | Citations (PDF) |
| 210 | The Importance of Genetic Counseling, DNA Diagnostics, and Cardiologic Family Screening in Left Ventricular Noncompaction Cardiomyopathy | 3.8 | 224 | Citations (PDF) |
| 211 | Single nucleotide polymorphisms in genes that are associated with a modified response to statin therapy: the Rotterdam Study | 2.6 | 16 | Citations (PDF) |
| 212 | Measures of body composition and risk of heart failure in the elderly: The Rotterdam study | 3.1 | 6 | Citations (PDF) |
| 213 | Eating Fish and Risk of Type 2 Diabetes | 6.2 | 107 | Citations (PDF) |
| 214 | Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemia | 2.2 | 18 | Citations (PDF) |
| 215 | Genetic Variant in the IGF2BP2 Gene May Interact With Fetal Malnutrition to Affect Glucose Metabolism | 4.2 | 58 | Citations (PDF) |
| 216 | Evaluation of risk prediction updates from commercial genome-wide scans | 4.2 | 69 | Citations (PDF) |
| 217 | SIRT1 Genetic Variation Is Related to BMI and Risk of Obesity | 4.2 | 129 | Citations (PDF) |
| 218 | Usefulness of Genetic Polymorphisms and Conventional Risk Factors to Predict Coronary Heart Disease in Patients With Familial Hypercholesterolemia | 1.8 | 31 | Citations (PDF) |
| 219 | SIRT1 genetic variation and mortality in type 2 diabetes: interaction with smoking and dietary niacin | 3.7 | 53 | Citations (PDF) |
| 220 | Diagnostic value of post-heparin lipase testing in detecting common genetic variants in the LPL and LIPC genes | 3.0 | 14 | Citations (PDF) |
| 221 | Genome-wide association study of blood pressure and hypertension | 25.2 | 1,296 | Citations (PDF) |
| 222 | Value of genetic profiling for the prediction of coronary heart disease | 2.9 | 45 | Citations (PDF) |
| 223 | Genetic Factors Are Relevant and Independent Determinants of Antihypertensive Drug Effects in a Multiracial Population | 2.0 | 11 | Citations (PDF) |
| 224 | Role of plasma adiponectin on the HDL-cholesterol raising effect of atorvastatin in patients with type 2 diabetes | 2.1 | 15 | Citations (PDF) |
| 225 | Prognostic Significance of QRS Duration in Patients With Suspected Coronary Artery Disease Referred for Noninvasive Evaluation of Myocardial Ischemia | 1.8 | 27 | Citations (PDF) |
| 226 | Arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and coronary heart disease risk in familial hypercholesterolemia | 1.5 | 24 | Citations (PDF) |
| 227 | ABCG8 gene polymorphisms, plasma cholesterol concentrations, and risk of cardiovascular disease in familial hypercholesterolemia | 1.5 | 44 | Citations (PDF) |
| 228 | 5-Lipoxygenase activating protein (ALOX5AP) gene variants associate with the presence of xanthomas in familial hypercholesterolemia | 1.5 | 17 | Citations (PDF) |
| 229 | Differences in characteristics and risk of cardiovascular disease in familial hypercholesterolemia patients with and without tendon xanthomas: A systematic review and meta-analysis | 1.5 | 109 | Citations (PDF) |
| 230 | Mortality Risk Prediction by an Insurance Company and Long-Term Follow-Up of 62,000 Men | 2.3 | 12 | Citations (PDF) |
| 231 | An RBP4 promoter polymorphism increases risk of type 2 diabetes | 7.5 | 71 | Citations (PDF) |
| 232 | Cox proportional hazards models have more statistical power than logistic regression models in cross-sectional genetic association studies | 3.0 | 68 | Citations (PDF) |
| 233 | Lack of association of two common polymorphisms on 9p21 with risk of coronary heart disease and myocardial infarction; results from a prospective cohort study | 7.1 | 26 | Citations (PDF) |
| 234 | Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia | 34.5 | 1,211 | Citations (PDF) |
| 235 | High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants | 1.5 | 57 | Citations (PDF) |
| 236 | An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients* | 3.6 | 67 | Citations (PDF) |
| 237 | Gene-load score of the renin–angiotensin–aldosterone system is associated with coronary heart disease in familial hypercholesterolaemia | 2.2 | 17 | Citations (PDF) |
| 238 | Replication study of 10 genetic polymorphisms associated with coronary heart disease in a specific high-risk population with familial hypercholesterolemia | 2.2 | 50 | Citations (PDF) |
| 239 | Shared Constitutional Risks for Maternal Vascular-Related Pregnancy Complications and Future Cardiovascular Disease | 6.6 | 208 | Citations (PDF) |
| 240 | Two Common Haplotypes of the Glucocorticoid Receptor Gene Are Associated with Increased Susceptibility to Cardiovascular Disease in Men with Familial Hypercholesterolemia | 4.0 | 28 | Citations (PDF) |
| 241 | Cholesteryl Ester Transfer Protein Inhibitor Torcetrapib and Off-Target Toxicity | 18.0 | 144 | Citations (PDF) |
| 242 | Efficacy of statins in familial hypercholesterolaemia: a long term cohort study | 0.1 | 656 | Citations (PDF) |
| 243 | Haplotype of the angiotensinogen gene is associated with coronary heart disease in familial hypercholesterolemia | 2.1 | 8 | Citations (PDF) |
| 244 | Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts | 25.2 | 794 | Citations (PDF) |
| 245 | Variants in MTNR1B influence fasting glucose levels | 25.2 | 701 | Citations (PDF) |
| 246 | Epistatic Effect of Cholesteryl Ester Transfer Protein and Hepatic Lipase on Serum High-Density Lipoprotein Cholesterol Levels | 4.0 | 25 | Citations (PDF) |
| 247 | Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients | 1.5 | 217 | Citations (PDF) |
| 248 | Complement Factor H polymorphism Y402H associates with inflammation, visual acuity, and cardiovascular mortality in the elderly population at large | 3.7 | 32 | Citations (PDF) |
| 249 | Heritabilities, apolipoprotein E, and effects of inbreeding on plasma lipids in a genetically isolated population: The Erasmus Rucphen Family Study | 5.3 | 26 | Citations (PDF) |
| 250 | Molecular screening for familial hypercholesterolaemia: consequences for life and disability insurance | 3.0 | 42 | Citations (PDF) |
| 251 | Plasma apolipoprotein A5 and triglycerides in type 2 diabetes | 7.5 | 82 | Citations (PDF) |
| 252 | A Functional Polymorphism in the Glucocorticoid Receptor Gene and Its Relation to Cardiovascular Disease Risk in Familial Hypercholesterolemia | 4.0 | 15 | Citations (PDF) |
| 253 | Effect of Low-Density Lipoprotein Cholesterol on Angiotensin II Sensitivity | 6.6 | 24 | Citations (PDF) |
| 254 | Low-Density Lipoprotein Receptor Genotype and Response to Pravastatin in Children With Familial Hypercholesterolemia | 18.0 | 77 | Citations (PDF) |
| 255 | Effect of low-density lipoprotein receptor mutation on lipoproteins and cardiovascular disease risk: a parent–offspring study | 1.5 | 36 | Citations (PDF) |
| 256 | Familial Defective Apolipoprotein B Versus Familial Hypercholesterolemia: An Assessment of Risk | 3.2 | 27 | Citations (PDF) |
| 257 | Molecular Analysis of Cardiovascular Disease: Some Delay due to Gene-Environment Interactions | 3.2 | 0 | Citations (PDF) |
| 258 | Efficacy and Safety of Statin Therapy in Children With Familial Hypercholesterolemia | 16.5 | 589 | Citations (PDF) |
| 259 | The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients | 7.3 | 280 | Citations (PDF) |
| 260 | Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia | 62.1 | 303 | Citations (PDF) |
| 261 | THE ANGIOTENSINOGEN M235T POLYMORPHISM AND SYSTOLIC BLOOD PRESSURE IN A DUTCH MULTI-ETHNIC STUDY | 2.1 | 0 | Citations (PDF) |
| 262 | Molecular variation at the apolipoprotein�B gene locus in relation to lipids and cardiovascular disease: a systematic meta-analysis | 2.9 | 54 | Citations (PDF) |
| 263 | The Apolipoprotein ε4 Allele Confers Additional Risk in Children with Familial Hypercholesterolemia | 2.2 | 15 | Citations (PDF) |
| 264 | Family History and Cardiovascular Risk in Familial Hypercholesterolemia | 18.0 | 137 | Citations (PDF) |
| 265 | Low-Density Lipoprotein Receptor Gene Mutations and Cardiovascular Risk in a Large Genetic Cascade Screening Population | 18.0 | 103 | Citations (PDF) |
| 266 | Hepatic lipase | 3.6 | 123 | Citations (PDF) |
| 267 | Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands | 62.1 | 473 | Citations (PDF) |
| 268 | Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study Commentary: Role of other genes and environment should not be overlooked in monogenic disease | 0.1 | 202 | Citations (PDF) |
| 269 | Alcohol consumption had no beneficial effect on serum lipids in a substantial proportion of patients with primary hyperlipidemia | 3.7 | 10 | Citations (PDF) |
| 270 | Additional risk factors influence excess mortality in heterozygous familial hypercholesterolaemia | 1.5 | 73 | Citations (PDF) |
| 271 | Identification of three new mutations of the low density lipoprotein receptor gene in Dutch familial hypercholesterolemic patients | 4.5 | 1 | Citations (PDF) |
| 272 | Increased risk for endogenous hypertriglyceridaemia is associated with an apolipoprotein C3 haplotype specified by the Sst I polymorphism | 3.0 | 37 | Citations (PDF) |
| 273 | Similar response to simvastatin in patients heterozygous for familial hypercholesterolemia with mRNA negative and mRNA positive mutations | 1.5 | 44 | Citations (PDF) |
| 274 | Effect of apolipoprotein E and insulin resistance on VLDL particles in combined hyperlipidemic patients | 1.5 | 7 | Citations (PDF) |
| 275 | The T705I mutation of the low density lipoprotein receptor gene (FH Paris-9) does not cause familial hypercholesterolemia | 2.9 | 28 | Citations (PDF) |
| 276 | Effects of Fish Oil on Oxidation Resistance of VLDL in Hypertriglyceridemic Patients | 6.0 | 50 | Citations (PDF) |
| 277 | Alcohol Consumption and Mortality among Women | 34.5 | 3 | Citations (PDF) |
| 278 | The relation of lipoprotein(a), apolipoprotein E2, and smoking in combined hyperlipidemia | 1.5 | 0 | Citations (PDF) |
| 279 | Mutations in the low density lipoprotein receptor gene of familial hypercholesterolemic patients detected by denaturing gradient gel electrophoresis and direct sequencing. | 3.6 | 73 | Citations (PDF) |
| 280 | Characterization of point mutations in the LDL receptor gene in Dutch patients with heterozygous familial hypercholesterolemia (FH) | 1.5 | 0 | Citations (PDF) |
| 281 | Title is missing! 0 | | 1 | Citations (PDF) |
| 282 | Title is missing! 0 | | 5 | Citations (PDF) |
| 283 | From In Vitro Efficacy to Long‐Term HbA1c Response for GLP‐1R/GlucagonR Agonism Using the 4GI‐HbA1c Systems Model | 2.7 | 0 | Citations (PDF) |
